NSPR
InspireMD IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$64.12M
P/E Ratio
—
EPS
$-0.76
Beta
0.94
52W High
$2.93
52W Low
$1.32
50-Day MA
$1.69
200-Day MA
$2.08
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
11.70
PEG Ratio
0.00
About InspireMD Inc
InspireMD, Inc., a medical device company, is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular disease in Europe, Latin America, the Middle East, and Asia. The company is headquartered in Tel Aviv, Israel.
Fundamentals
| Revenue (TTM) | $8.98M |
| Gross Profit (TTM) | $2.65M |
| EBITDA | $-49.14M |
| Operating Margin | -383.70% |
| Return on Equity | -106.90% |
| Return on Assets | -53.40% |
| Revenue/Share (TTM) | $0.14 |
| Book Value | $1.27 |
| Price-to-Book | 1.31 |
| Price-to-Sales (TTM) | 7.14 |
| EV/Revenue | 2.356 |
| EV/EBITDA | 0.52 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 61.60% |
| Shares Outstanding | $46.80M |
| Float | $26.52M |
| % Insiders | 20.74% |
| % Institutions | 49.51% |
Analyst Ratings
Consensus ($5.00 target)
2
Strong Buy1
BuyData last updated: 4/9/2026